tert-Butyl 2-(2-(pyrrolidin-1-yl)pyridin-3-yl)piperidine-1-carboxylate

Catalog No. :
ACXIQC163
CAS No. :
1352485-06-3
Molecular Formula :
C19H29N3O2
Molecular Weight :
331.46

IUPAC Name:tert-butyl 2-(2-(pyrrolidin-1-yl)pyridin-3-yl)piperidine-1-carboxylate

tert-Butyl 2-(2-(pyrrolidin-1-yl)pyridin-3-yl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$722.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(2-(pyrrolidin-1-yl)pyridin-3-yl)piperidine-1-carboxylate
IUPAC Nametert-butyl 2-(2-(pyrrolidin-1-yl)pyridin-3-yl)piperidine-1-carboxylate
Molecular FormulaC19H29N3O2
Molecular Weight331.46
SMILESO=C(N1CCCCC1C2=CC=CN=C2N3CCCC3)OC(C)(C)C
InChI KeyVKSPKLXTLCOCFX-UHFFFAOYSA-N
Synonym2-Pyrrolidin-1-yl-3,4,5,6-tetrahydro-2H-[2,3]bipyridinyl-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 2-[2-(1-pyrrolidinyl)-3-pyridinyl]-, 1,1-dimethylethyl ester;tert-Butyl 2-(2-(pyrrolidin-1-yl)pyridin-3-yl)piperidine-1-carboxylate
CAS No.1352485-06-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXIQC163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXIQC163 route product structure diagram
    ACXIQC1631352485-06-3
Inquiry

2. ACXIQC163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXIQC163 route product structure diagram
    ACXIQC1631352485-06-3
Inquiry

Comments (0)